EDGAR Filing Documents for 0001193125-20-065071

Form CORRESP - Correspondence:

SEC Accession No. 0001193125-20-065071

Filing Date

2020-03-06

Accepted

2020-03-06 16:07:07

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.htm	CORRESP	16961
2	GRAPHIC	g846749img1.jpg	GRAPHIC	5139
3	GRAPHIC	g846749img2.jpg	GRAPHIC	3642
	Complete submission text file	0001193125-20-065071.txt		30247

Mailing Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801

Business Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801 (857) 444-0553

Ayala Pharmaceuticals, Inc. (Filer) CIK: 0001797336 (see all company filings)

IRS No.: 823578375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)